These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30672775)

  • 21. Desmoplastic malignant melanoma: diagnosis of early clinical lesions.
    Wharton JM; Carlson JA; Mihm MC
    Hum Pathol; 1999 May; 30(5):537-42. PubMed ID: 10333224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of fibrogenic cytokines in desmoplastic malignant melanoma.
    Kubo M; Kikuchi K; Nashiro K; Kakinuma T; Hayashi N; Nanko H; Tamaki K
    Br J Dermatol; 1998 Aug; 139(2):192-7. PubMed ID: 9767231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melan-A/Mart-1 expression in various melanocytic lesions and in non-melanocytic soft tissue tumours.
    Orosz Z
    Histopathology; 1999 Jun; 34(6):517-25. PubMed ID: 10383696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Desmoplastic malignant melanoma of the oral mucosa. An underrecognized diagnostic pitfall.
    Kilpatrick SE; White WL; Browne JD
    Cancer; 1996 Aug; 78(3):383-9. PubMed ID: 8697380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of SOX-10 immunohistochemical expression in canine melanoma and non-melanocytic tumors by tissue microarray.
    King E; Cook M; Wittorff H; Dirksen W; Kisseberth WC; Jennings RN
    Vet Pathol; 2024 Nov; 61(6):896-903. PubMed ID: 39239974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic value of Sox10 immunohistochemical staining for the detection of metastatic melanoma in sentinel lymph nodes.
    Blochin E; Nonaka D
    Histopathology; 2009 Nov; 55(5):626-8. PubMed ID: 19912373
    [No Abstract]   [Full Text] [Related]  

  • 27. Expression of Sox-9 in metastatic melanoma--a potential diagnostic pitfall.
    Rao P; Fuller GN; Prieto VG
    Am J Dermatopathol; 2010 May; 32(3):262-266. PubMed ID: 20098296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sox10-Positive Cells Within Scars: A Potential Diagnostic Pitfall.
    Harvey NT; Acott NJ; Wood BA
    Am J Dermatopathol; 2017 Oct; 39(10):791-793. PubMed ID: 27759704
    [No Abstract]   [Full Text] [Related]  

  • 29. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis.
    El Shabrawi-Caelen L; Kerl H; Cerroni L
    Am J Dermatopathol; 2004 Oct; 26(5):364-6. PubMed ID: 15365366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A newly developed mouse monoclonal SOX10 antibody is a highly sensitive and specific marker for malignant melanoma, including spindle cell and desmoplastic melanomas.
    Tacha D; Qi W; Ra S; Bremer R; Yu C; Chu J; Hoang L; Robbins B
    Arch Pathol Lab Med; 2015 Apr; 139(4):530-6. PubMed ID: 25436903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical distinction of cutaneous spindle cell carcinoma.
    Morgan MB; Purohit C; Anglin TR
    Am J Dermatopathol; 2008 Jun; 30(3):228-32. PubMed ID: 18496422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HMB-45 recognizes stimulated melanocytes.
    Smoller BR; McNutt NS; Hsu A
    J Cutan Pathol; 1989 Apr; 16(2):49-53. PubMed ID: 2668355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical expression of p16 in desmoplastic melanoma.
    Blokhin E; Pulitzer M; Busam KJ
    J Cutan Pathol; 2013 Sep; 40(9):796-800. PubMed ID: 23808580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Actin-rich desmoplastic malignant melanoma: report of three cases.
    Riccioni L; Di Tommaso L; Collina G
    Am J Dermatopathol; 1999 Dec; 21(6):537-41. PubMed ID: 10608246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SOX10 Immunostaining in granulomatous dermatoses and benign reactive lymph nodes.
    Merelo Alcocer V; Flamm A; Chen G; Helm K
    J Cutan Pathol; 2019 Aug; 46(8):586-590. PubMed ID: 30957251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
    de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
    Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SOX10 expression in malignant melanoma, carcinoma, and normal tissues.
    Mohamed A; Gonzalez RS; Lawson D; Wang J; Cohen C
    Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):506-10. PubMed ID: 23197006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of S-100 versus hematoxylin and eosin staining for evaluating dermal invasion and peripheral margins by desmoplastic malignant melanoma.
    Eng W; Tschen JA
    Am J Dermatopathol; 2000 Feb; 22(1):26-9. PubMed ID: 10698212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A light microscopic and immunohistochemical evaluation of scars.
    Kamath NV; Ormsby A; Bergfeld WF; House NS
    J Cutan Pathol; 2002 Jan; 29(1):27-32. PubMed ID: 11841514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma.
    Busam KJ; Chen YT; Old LJ; Stockert E; Iversen K; Coplan KA; Rosai J; Barnhill RL; Jungbluth AA
    Am J Surg Pathol; 1998 Aug; 22(8):976-82. PubMed ID: 9706977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.